Adriamycin was shown to induce E-cadherin-mediated cell–cell adhesion by increasing the expression of E-cadherin and β-catenin while decreasing the expression of Mucin 1 in YMB-S breast cancer cells [209]. The gene discussed is CDH1; the disease is breast carcinoma.